New Paper Addresses Health Care Costs and Patient Assistance Programs

Categorized in -


Patient Assistance Programs:
Essential Patient Access to Vital Medicines

Recently, some health care analysts have broadly criticized patient assistance programs (PAPs) as a significant cause of growth in prescription drug spending and overall health care costs.  In a new paper, NORD addresses this issue and explains the essential function of PAPs for people with rare diseases.

Read the full statement here.